BYSI

1.70

1.19% 0.02

Dopo l'orario di chiusura: 1.70

Beyondspring Inc (BYSI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$1.68

Aprire:

$1.66

Volume 24 ore:

7,899

Relative Volume:

0.41

Capitalizzazione di mercato:

$68.54M

Reddito:

$1.88M

Utile/perdita netta:

$-15.57M

Rapporto P/E:

-4.25

EPS:

-0.4

Flusso di cassa netto:

$-50.09M

1 W Prestazione:

+2.41%

1M Prestazione:

+13.33%

6M Prestazione:

-2.30%

1 anno Prestazione:

-50.44%

Intervallo 1D:

$1.64

$1.7544

Intervallo di 1 settimana:

$1.62

$1.769

Portata 52W:

$0.98

$3.625

Beyondspring Inc Stock (BYSI) Company Profile

Nome

Beyondspring Inc

Settore

Healthcare (1173)

Industria

Biotechnology (666)

Telefono

646-528-4184

Indirizzo

100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY

Dipendente

Cinguettio

@BeyondSpringInc

Prossima data di guadagno

2024-08-05

Ultimi documenti SEC

BYSI's Discussions on Twitter

Confronta BYSI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BYSI Beyondspring Inc	1.70	66.93M	1.88M	-15.57M	-50.09M	-0.40
ONC Beigene Ltd Adr	241.43	27.03B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	436.00	112.64B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.335	40.86M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	588.34	64.17B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	75.06	6.07B	0	-153.72M	-103.81M	-2.00

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-12-02	Downgrade	BofA Securities	Buy → Underperform
2021-12-02	Downgrade	Jefferies	Buy → Hold
2021-12-01	Downgrade	H.C. Wainwright	Buy → Neutral
2021-12-01	Downgrade	William Blair	Outperform → Mkt Perform
2021-09-09	Iniziato	Robert W. Baird	Outperform
2021-08-04	Aggiornamento	H.C. Wainwright	Neutral → Buy
2021-04-05	Downgrade	H.C. Wainwright	Buy → Neutral
2021-01-11	Iniziato	BofA Securities	Buy
2020-12-29	Iniziato	Evercore ISI	Outperform
2020-02-07	Iniziato	Jefferies	Buy
2020-01-10	Iniziato	Nomura	Buy
2019-12-03	Iniziato	William Blair	Outperform
2019-07-10	Reiterato	H.C. Wainwright	Buy
2019-04-30	Downgrade	Maxim Group	Buy → Hold
2018-10-25	Reiterato	Maxim Group	Buy

Mostra tutto

Beyondspring Inc Borsa (BYSI) Ultime notizie

May 23, 2025

Neutropenia Drugs Market Revenue to Surpass USD 24.2 Billion by 2033 with 4.7% CAGR - openPR.com

May 23, 2025

May 22, 2025

BeyondSpring Reports First?Quarter 2025 Financial Results and Provides Corporate Update | BYSI Stock News - GuruFocus

May 12, 2025

BeyondSpring Inc. Reports Positive Early Results for Plinabulin in Metastatic Cancer and Updates on SEED Therapeutics' Progress - Nasdaq

May 12, 2025

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 12, 2025

May 08, 2025

BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 08, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Apr 29, 2025

SEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156 - MSN

Apr 29, 2025

Apr 10, 2025

BeyondSpring (NASDAQ:BYSI) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat

Apr 10, 2025

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges - Investing.com India

Apr 04, 2025

Mar 30, 2025

BeyondSpring (NASDAQ:BYSI) Trading Down 3.8%Here's Why - MarketBeat

Mar 30, 2025

Mar 29, 2025

BeyondSpring’s 2024 Progress and Strategic Milestones - TipRanks

Mar 29, 2025

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline - Investing.com

Mar 28, 2025

Mar 27, 2025